MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Proceeds from atmoffering$17,049K Maturities of marketabledebt securities$57,990K Net cash provided by(used in) financing...$16,489K Net cash provided by(used in) investing...$11,087K Effect of foreignexchange rates on cash and...$43K Canceled cashflow$560K Canceled cashflow$46,903K Net decrease incash, cash...-$16,654K Canceled cashflow$27,619K Payment of issuancecosts related to atm...$560K Purchases of marketabledebt securities$44,284K Purchases of property andequipment$2,619K Net cash used inoperating activities -...-$44,273K Depreciation andamortization$12,315K Stock-based compensation$7,595K Non-cash lease expense$6,143K Loss on equity methodinvestment-$4,673K Accounts payable,accrued expenses and...$3,944K Changes in operatingassets and liabilities-$3,713K Other non-currentassets-$48K Accretion of discount onmarketable securities-$29K Net cash used inoperating activities -...-$42,173K Net cash used inoperating activities -...-$2,100K Canceled cashflow$38,460K Net loss fromcontinuing operations-$57,321K Prepaid expenses andother current assets$6,705K Operating leaseliabilities, current and...-$5,748K Other non-currentliabilities-$5,366K Deferred revenue-$3,032K (gain) loss oninvestments$1,987K Other non-cashactivity$474K
Cash Flow

Ginkgo Bioworks Holdings, Inc. (DNABW)

Ginkgo Bioworks Holdings, Inc. (DNABW)

source: myfinsight.com